BIRMINGHAM, Ala. , May 13, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it plans to build a freestanding, 60-bed inpatient rehabilitation hospital in Houston, Texas . The hospital will be located at 3000 Yellowstone Boulevard.
Complementing local acute care services, the future hospital will serve patients recovering from debilitating illnesses and injuries, including strokes and other neurological disorders, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. In addition to 24–hour nursing care, this hospital will offer physical, occupational and speech therapies to restore functional ability and quality of life. Care will be provided by highly specialized nurses, therapists and physicians.
The hospital will feature all private patient rooms, a spacious therapy gym with advanced rehabilitation technologies and an activities of daily living suite, cafeteria, dining room, pharmacy and therapy courtyard.
"We are excited to expand and grow our rehabilitation services in Houston, Texas ," said Frank Brown , president of Encompass Health's Southwest region. "Through the new inpatient rehabilitation hospital, we will provide our patients with coordinated and connected care that meets them where they are in their healthcare journeys and makes a positive difference in their lives."
The planned hospital, once opened, will become part of Encompass Health's national network of inpatient rehabilitation hospitals and home health and hospice agencies. The Company's Texas footprint includes 26 inpatient rehabilitation hospitals; a future hospital in Amarillo, Texas ; one hospital under construction in Prosper, Texas ; 51 home health locations; and 15 hospice locations.
About Encompass Health As a national leader in integrated healthcare services, Encompass Health (NYSE: EHC) offers both facility–based and home–based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that includes 148 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico , the Company provides high–quality, cost-effective integrated healthcare. Encompass Health is ranked as one of Fortune's 100 Best Companies to Work For. For more information, visit encompasshealth.com, or follow us on our newsroom, Twitter, Instagram and Facebook.
Forward-Looking Statements Statements contained in this press release which are not historical facts, such as those relating to the likelihood, timing and effects of the completion of this hospital project, are forward-looking statements. In addition, Encompass Health may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Encompass Health's actual results or events may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual results or events to differ materially from those anticipated include, but are not limited to, the regulatory review and approval process, any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings that may be brought by or against the Company; the possibility this project will experience unexpected delays; the ability to successfully complete this project consistent with Encompass Health's growth strategy, including realization of anticipated revenues and avoidance of unforeseen exposure to liabilities; the continued spread of COVID-19, including the speed, depth, geographic reach and duration of the spread; the actions to be taken by Encompass Health in response to the COVID-19 pandemic; changes in the regulation of the healthcare industry at either or both of the federal and state levels; competitive pressures in the healthcare industry and Encompass Health's response thereto; the hospital's ability to maintain proper local, state and federal licensing; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems; Encompass Health's ability to attract and retain nurses, therapists, and other healthcare professionals in a highly competitive environment with often severe staffing shortages and the impact on Encompass Health's labor expenses from potential union activity and staffing shortages; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; general conditions in the economy and capital markets; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10-K for the year ended Dec. 31, 2021 and Form 10-Q for the quarter ended March 31, 2022 .
Media contact: Erin Wendel -Ritter | 205-970-5912 erin.wendel-ritter@encompasshealth.com
Investor Relations contact: Mark Miller | 205-970-5860 mark.miller@encompasshealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-plans-to-build-a-60-bed-inpatient-rehabilitation-hospital-in-houston-texas-301546966.html
"I was in a medically induced coma for six weeks. There were times I was fully conscious, but I couldn't open my eyes, couldn't move a muscle, and couldn't speak. It was terrifying."View Entire Post ›
The company's current treatments dominate the cystic fibrosis market, but it's the pipeline that makes this stock so intriguing.
Part of the answer: ‘Your mileage may vary’ in the face of an ever-mutating, immune-evading virus
From increased equity to the popularity of wearable medical devices, here are five predictions about the future of the American health care industry.
Top health officials warn COVID-19 projection models show a significant wave is on the horizon. They're urging people to get vaccinated and boosted. https://www.abcactionnews.com/news/coronavirus/health-officials-urge-covid-19-vaccinations-and-boosters-as-cases-rise
Bodybuilder Charles Atlas sought to turn Americans from 'Chump to Champ.' Lee Lockwood/Getty ImagesPromotions for “The End of Men,” Fox News host Tucker Carlson’s forthcoming documentary, lament “The total collapse of testosterone levels in American men.” Carlson’s central premise is that modern society has devitalized American men. Strength, drive and aggression are no longer in vogue, and Americans, as a result, are become weaker. This, the film implies, has ramifications for the country itsel
The comedian’s one-woman show “Oh God, A Show About Abortion” unpacks why talking about abortion shouldn’t be so thorny.
"It's creepy and gross. Stop that."View Entire Post ›
Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus. Ill effects from the condition can include fatigue, pain, neurological issues and even changes in mental health. Initially, public health officials believed that only a small minority of…
A French court has ordered Sanofi to pay more than 400,000 euros ($416,440) in damages to a family whose child suffered from a form of autism caused by its epilepsy drug Valproate, saying the drugmaker failed to inform about known side effects. The link, alongside physical malformation, had also been recognised in a landmark class action ruling in January, which could potentially lead to hundreds of millions of euros in compensation, though Sanofi said it would file an appeal. The latest ruling, made last week and seen by Reuters on Saturday, states that Sanofi must have known the risk that the drug, if taken by pregnant women, could cause malformations and "neuro-behavioural disorders" in children, which should have been mentioned in its attached leaflet.
Intra-Cellular Therapies (NASDAQ: ITCI), a biotech that specializes in therapies to treat complex psychiatric and neurologic diseases, saw its shares rise 21.4% this week through today's close, according to data from S&P Global Market Intelligence. The drug was initially approved by the Food and Drug Administration (FDA) in the first quarter of 2020 as a treatment for adult schizophrenia. In late December, an additional indication, as a monotherapy or adjunct treatment for bipolar depression, was approved by the FDA.
It’s expected that, after two years of multiple disruptions caused by the COVID-19 pandemic, there would be repercussions on our collective mental health. As recent research has shown, it is heavily impacting children and teens.
Feeling some dizziness? Experts say vertigo is serious and can be a sign of COVID-19. Here’s what to know about the symptom and when to see a doctor.
Dr. Anthony Fauci, the nation’s top infectious disease specialist, told The Root today that cases of the deadly Covid-19 virus are slowly rising again across the country and warned that Black Americans could be particularly at risk in the event a more aggressive variant should appear. Fauci spoke with The Root this afternoon where he clarified his own comments about where the nation stood on the status of the pandemic as the country nears the milestone of 1 million deaths from the virus, which o
(Bloomberg) -- Fallout from the nursing shortage that’s plaguing U.S. hospitals got so bad that 16% of the nurses at one western Pennsylvania facility left last year, and 220 of those remaining staged a five-day walkout that halted elective surgery.Most Read from BloombergElon Musk Sows Doubt Over His $44 Billion Twitter TakeoverSony PlayStation Staff Fume Over CEO’s Abortion CommentsApple Testing iPhones That Ditch Lightning Ports in Favor of USB-CUkraine Latest: US Senator Delays Aid Vote; Rus
Podcast host Deborah James has praised the Duke of Cambridge for "going above and beyond to make a very special memory" after he made her a dame at her family home.
A string of British health companies have won prizes at the 2022 Prix Galien UK Awards dedicated to innovation that improves the human condition.
‘What people don’t understand is that abortion care is part of pregnancy care’ — Here's what the U.S. will look like if Roe v. Wade is overturned » Sign up for our newsletter KnowThis to get the biggest stories of the day delivered straight to your inbox: https://go.nowth.is/knowthis_youtube » Subscribe to NowThis: http://go.nowth.is/News_Subscribe For more U.S. news & politics, subscribe to NowThis News. #AbortionRights #Abortion #ReproductiveRights #Politics #News #NowThis This video "How Restricting Abortion Rights Will Change the U.S. ", first appeared on https://nowthisnews.com/.
SEOUL (Reuters) -North Korean leader Kim Jong Un said on Saturday the spread of COVID-19 had thrust his country into "great turmoil" and called for an all-out battle to overcome the outbreak, as 21 daily deaths were reported among people with fever. North Korea this week acknowledged for the first time a COVID outbreak, imposing a nationwide lockdown. "The spread of the malignant epidemic is a great turmoil to fall on our country since the founding," Kim told an emergency meeting of the ruling Workers' Party, according to state news agency KCNA.
The pill has become an increasingly important tool in the nation’s defense against COVID-19 as mask mandates have lifted and people have returned to their non-distanced lives.